Pharmacogenomic tests to predict clozapine response

Summary

Health Technology Wales researchers searched for evidence on the clinical and cost effectiveness of pharmacogenomic testing to predict clozapine response and clozapine-related adverse events in people with treatment-resistant schizophrenia.

A decision on wheBased on the evidence identified, HTW’s Assessment Group concluded not to progress this topic to evidence appraisal.